EGLN3 and anemia: Our results not only strongly suggest that salidroside might be a promising small molecule drug for diabetic HLI, but might also be a potential drug for other diseases, such as preeclampsia and severe anemia due to impaired iron uptake, in which aberrant PHD3 upregulation occurs [49, 50].